Replies to post #188107 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Thanks for posting this Lykiri - Dr. Lim actually speaks about the DCVax-L trial and the technology for several minutes, up to about 23:25, even posting the survival chart that so many of us have been trying to count up the censored and OS patients from.

Great find, as usual.

American Brain Tumor Association
18 jun. 2018

In this webinar, Dr. Michael Lim MD, Professor of Neurosurgery, Oncology, Otolaryngology, and Radiation Oncology at Johns Hopkins takes a comprehensive look into immunotherapy as a treatment option for brain tumors. Immunotherapy has gained a great deal of attention for many different tumors. Dr. Lim will discuss the state of the field for immunotherapy for GBM and future directions.

Dr. Michael Lim MD, and DCVAX-L trial:
Min.20.09
Quote:
“This is very early on but again very interesting results”
Quote:
“We think that it’s still a very interesting and promising approach”